"acute myeloid leukemia" trang 4 - tải miễn phí từ tailieunhanh
Enhancing SHP-1 expression with 5-azacytidine may inhibit STAT3 activation and confer sensitivity in lestaurtinib (CEP-701)-resistant FLT3-ITD positive acute myeloid leukemia

Enhancing SHP-1 expression with 5-azacytidine may inhibit STAT3 activation and confer sensitivity in lestaurtinib (CEP-701)-resistant FLT3-ITD positive acute myeloid leukemia
11    30    1
LINC00649 underexpression is an adverse prognostic marker in acute myeloid leukemia

LINC00649 underexpression is an adverse prognostic marker in acute myeloid leukemia
20    22    1
DECIDER: Prospective randomized multicenter phase II trial of low-dose decitabine (DAC) administered alone or in combination with the histone deacetylase inhibitor valproic acid (VPA) and all-trans retinoic acid (ATRA) in patients > 60 years with acute myeloid leukemia who are ineligible for induction chemotherapy

DECIDER: Prospective randomized multicenter phase II trial of low-dose decitabine (DAC) administered alone or in combination with the histone deacetylase inhibitor valproic acid (VPA) and all-trans retinoic acid (ATRA) in patients > 60 years with acute myeloid leukemia who are ineligible for induction chemotherapy
8    62    1
Overexpression of primary microRNA 221/222 in acute myeloid leukemia

Overexpression of primary microRNA 221/222 in acute myeloid leukemia
12    30    1
Radotinib enhances cytarabine (Ara-C)- induced acute myeloid leukemia cell death

Radotinib enhances cytarabine (Ara-C)- induced acute myeloid leukemia cell death
15    43    1
Wilms’ tumor gene 1 is an independent prognostic factor for pediatric acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation

Wilms’ tumor gene 1 is an independent prognostic factor for pediatric acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation
12    45    3
The characteristics of circRNA as competing endogenous RNA in pathogenesis of acute myeloid leukemia

The characteristics of circRNA as competing endogenous RNA in pathogenesis of acute myeloid leukemia
10    31    1
A deconvolution method and its application in analyzing the cellular fractions in acute myeloid leukemia samples

A deconvolution method and its application in analyzing the cellular fractions in acute myeloid leukemia samples
15    21    1
The correlation of next-generation sequencing-based genotypic profiles with clinicopathologic characteristics in NPM1- mutated acute myeloid leukemia

The correlation of next-generation sequencing-based genotypic profiles with clinicopathologic characteristics in NPM1- mutated acute myeloid leukemia
11    51    1
Monitoring of post-transplant MLL-PTD as minimal residual disease can predict relapse after allogeneic HSCT in patients with acute myeloid leukemia and myelodysplastic syndrome

Monitoring of post-transplant MLL-PTD as minimal residual disease can predict relapse after allogeneic HSCT in patients with acute myeloid leukemia and myelodysplastic syndrome
11    58    3
Targeting CD33 for acute myeloid leukemia therapy

Targeting CD33 for acute myeloid leukemia therapy
7    39    3
Combination of midostaurin and ATRA exerts dose-dependent dual effects on acute myeloid leukemia cells with wild type FLT3

Combination of midostaurin and ATRA exerts dose-dependent dual effects on acute myeloid leukemia cells with wild type FLT3
14    15    1
Construction and validation of a fatty acid metabolism risk signature for predicting prognosis in acute myeloid leukemia

Construction and validation of a fatty acid metabolism risk signature for predicting prognosis in acute myeloid leukemia
12    14    1
Efficacy and safety of venetoclax combined with hypomethylating agents for relapse of acute myeloid leukemia and myelodysplastic syndrome post allogeneic hematopoietic stem cell transplantation: A systematic review and meta-analysis

Efficacy and safety of venetoclax combined with hypomethylating agents for relapse of acute myeloid leukemia and myelodysplastic syndrome post allogeneic hematopoietic stem cell transplantation: A systematic review and meta-analysis
12    1    1
PD-L1 stimulation can promote proliferation and survival of leukemic cells by influencing glucose and fatty acid metabolism in acute myeloid leukemia

PD-L1 stimulation can promote proliferation and survival of leukemic cells by influencing glucose and fatty acid metabolism in acute myeloid leukemia
9    5    1
Prognostic value of IDH2R140 and IDH2R172 mutations in patients with acute myeloid leukemia: A systematic review and meta-analysis

Prognostic value of IDH2R140 and IDH2R172 mutations in patients with acute myeloid leukemia: A systematic review and meta-analysis
14    5    1
Association between serum albumin and 60-day mortality in Chinese Hakka patients with non-APL acute myeloid leukemia: A retrospective cohort study

Association between serum albumin and 60-day mortality in Chinese Hakka patients with non-APL acute myeloid leukemia: A retrospective cohort study
9    1    1
Comprehensive analysis of ID genes reveals the clinical and prognostic value of ID3 expression in acute myeloid leukemia using bioinformatics identification and experimental validation

Comprehensive analysis of ID genes reveals the clinical and prognostic value of ID3 expression in acute myeloid leukemia using bioinformatics identification and experimental validation
12    3    1
Evaluating the prognostic value of CD56 in pediatric acute myeloid leukemia

Evaluating the prognostic value of CD56 in pediatric acute myeloid leukemia
9    2    1
Identification of TLN1 as a prognostic biomarker to affect cell proliferation and differentiation in acute myeloid leukemia

Identification of TLN1 as a prognostic biomarker to affect cell proliferation and differentiation in acute myeloid leukemia
15    1    1